Number of Shares
16,199.00
Current Holdings Value*
kr1.11 Mil
% of Portfolio
0.97%
Total Estimate Gain
kr9.30 Mil
% of Total Estimate Gain
188.30%

GuideMark World ex-US Fund's Novo Nordisk AS Holding Summary

As of 2025-03-31, GuideMark World ex-US Fund held 16,199.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr1.11 Mil. This investment constitutes 0.97% of their stock portfolio, and GuideMark World ex-US Fund now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q3. And since then GuideMark World ex-US Fund has made 2 purchases of OCSE:NOVO B, at an average price of kr171.39, for a total of 28,826.00 shares. In addition, there have been 9 sales at an average price of kr559.99 for 12,627.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr442.80, GuideMark World ex-US Fund's estimated gain on his OCSE:NOVO B holdings is kr9.30 Mil, reflecting a 188.30% gain to date.

GuideMark World ex-US Fund OCSE:NOVO B (kr442.80) Holding Chart

GuideMark World ex-US Fund OCSE:NOVO B (kr442.80) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1